Overcoming Vector & Cargo Immunogenicity to Improve Therapeutic Persistence in Patients
- Examining how immune responses to vectors and cargo drive blood clearance of gene editing therapies to help you identify strategies that improve therapeutic persistence
- Exploring approaches to reduce immune-mediated clearance during repeat dosing to equip you with practical solutions for maintaining therapeutic efficacy over time
- Assessing how leading companies are engineering vectors to evade immune recognition to give you real-world insights into overcoming immunogenicity in your program